| 1 |
33850897 | A metabolism-related gene signature for predicting the prognosis and therapeutic responses in patients with hepatocellular carcinoma. | 2021 Mar |
2 |
| 2 |
33990090 | Use of Circulating Tumor DNA for the Clinical Management of Metastatic Castration-Resistant Prostate Cancer: A Multicenter, Real-World Study. | 2021 May 14 |
1 |
| 3 |
34743450 | [Clinical features and prognostic value of TP53 mutation in Chinese prostate cancer patients]. | 2021 Nov 1 |
3 |
| 4 |
30350349 | NFIB promotes cell survival by directly suppressing p21 transcription in TP53-mutated triple-negative breast cancer. | 2019 Feb |
1 |
| 5 |
31601253 | Inhibiting PAD2 enhances the anti-tumor effect of docetaxel in tamoxifen-resistant breast cancer cells. | 2019 Oct 10 |
1 |
| 6 |
29207126 | Melatonin enhances the apoptotic effects and modulates the changes in gene expression induced by docetaxel in MCF‑7 human breast cancer cells. | 2018 Feb |
1 |
| 7 |
30555232 | Activation of polymeric nanoparticle intracellular targeting overcomes chemodrug resistance in human primary patient breast cancer cells. | 2018 |
1 |
| 8 |
27637603 | The Presence of Serum p53 Antibody Predicts the Pathological Tumor Response to Neoadjuvant Chemotherapy with Docetaxel, Cisplatin and Fluorouracil (DCF) in Esophageal Squamous Cell Carcinoma. | 2017 Feb |
1 |
| 9 |
28199187 | Combinatorial effect of curcumin with docetaxel modulates apoptotic and cell survival molecules in prostate cancer. | 2017 Mar 1 |
1 |
| 10 |
28901493 | High pemetrexed sensitivity of docetaxel-resistant A549 cells is mediated by TP53 status and downregulated thymidylate synthase. | 2017 Nov |
2 |
| 11 |
26511813 | Caveolin-1 Modulates Docetaxel-Induced Cell Death in Breast Cancer Cell Subtypes through Different Mechanisms. | 2016 Apr |
2 |
| 12 |
27352049 | Influence of Matrices on 3D-Cultured Prostate Cancer Cells' Drug Response and Expression of Drug-Action Associated Proteins. | 2016 |
1 |
| 13 |
26251569 | Zinc supplementation induces apoptosis and enhances antitumor efficacy of docetaxel in non-small-cell lung cancer. | 2015 |
1 |
| 14 |
26512780 | Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations. | 2015 Dec 1 |
3 |
| 15 |
24722580 | Gonadotropin-releasing hormone agonists sensitize, and resensitize, prostate cancer cells to docetaxel in a p53-dependent manner. | 2014 |
6 |
| 16 |
22996738 | Functional p53 determines docetaxel sensitivity in prostate cancer cells. | 2013 Mar |
18 |
| 17 |
23482764 | β-Elemene and taxanes synergistically induce cytotoxicity and inhibit proliferation in ovarian cancer and other tumor cells. | 2013 Mar |
1 |
| 18 |
23563592 | p53 interferes with microtubule-stabilizing agent-induced apoptosis in prostate and colorectal cancer cells. | 2013 Jun |
7 |
| 19 |
21351099 | Low-dose docetaxel enhances the sensitivity of S-1 in a xenograft model of human castration resistant prostate cancer. | 2012 Jan 15 |
1 |
| 20 |
21373875 | TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine ± trastuzumab. | 2012 Apr |
1 |
| 21 |
21968939 | Lenalidomide enhances the anti-prostate cancer activity of docetaxel in vitro and in vivo. | 2012 Jun 1 |
1 |
| 22 |
22200537 | Liposomal formulations of Etoposide and Docetaxel for p53 mediated enhanced cytotoxicity in lung cancer cell lines. | 2012 Mar |
2 |
| 23 |
22425996 | A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response. | 2012 Mar 18 |
2 |
| 24 |
22445862 | Docetaxel and 5-fluorouracil induce human p53 tumor suppressor gene transcription via a short sequence at core promoter element. | 2012 Aug |
4 |
| 25 |
21273177 | Randomized phase II trial of concurrent versus sequential bortezomib plus docetaxel in advanced non-small-cell lung cancer: a California cancer consortium trial. | 2011 Jan |
1 |
| 26 |
21380817 | Role of nonsteroidal anti-inflammatory drug-activated gene-1 in docetaxel-induced cell death of human colorectal cancer cells with different p53 status. | 2011 Feb |
7 |
| 27 |
21481270 | Evaluation of HER2 and p53 expression in predicting response to docetaxel-based first-line chemotherapy in advanced breast cancer. | 2011 Apr 11 |
2 |
| 28 |
21656826 | Resistance to docetaxel-induced apoptosis in prostate cancer cells by p38/p53/p21 signaling. | 2011 Aug 1 |
6 |
| 29 |
22848254 | Growth inhibition and enhanced chemosensitivity induced by down-regulation of Aurora-A in human renal cell carcinoma Caki-2 cells using short hairpin RNA. | 2011 Jul |
1 |
| 30 |
20372849 | Pre-radiation enhances the cytotoxicity of docetaxel in head and neck squamous cell carcinoma cells. | 2010 May |
2 |
| 31 |
21159614 | Contrasting effects of nutlin-3 on TRAIL- and docetaxel-induced apoptosis due to upregulation of TRAIL-R2 and Mcl-1 in human melanoma cells. | 2010 Dec |
1 |
| 32 |
18472237 | p53 expression in concurrent chemoradiotherapy with docetaxel for head and neck squamous cell carcinoma. | 2009 Feb |
3 |
| 33 |
18758819 | In vitro effect of radiation, antibody to epidermal growth factor receptor and Docetaxel in human head and neck squamous carcinoma cells with mutant P53 and over-expressed EGFR. | 2009 Feb |
1 |
| 34 |
20067883 | Vitamin A family compounds, estradiol, and docetaxel in proliferation, apoptosis and immunocytochemical profile of human ovary endometrioid cancer cell line CRL-11731. | 2009 |
1 |
| 35 |
18281755 | [Prediction of response to docetaxel in breast cancer]. | 2008 Feb |
1 |
| 36 |
16821082 | Possible involvement of CCT5, RGS3, and YKT6 genes up-regulated in p53-mutated tumors in resistance to docetaxel in human breast cancers. | 2007 Mar |
7 |
| 37 |
17159504 | 15-Deoxy-Delta12,14-prostaglandin J2 enhances docetaxel anti-tumor activity against A549 and H460 non-small-cell lung cancer cell lines and xenograft tumors. | 2007 Jan |
1 |
| 38 |
17369602 | p-53 gene mutations as a predictive marker in a population of advanced breast cancer patients randomly treated with doxorubicin or docetaxel in the context of a phase III clinical trial. | 2007 Jun |
1 |
| 39 |
17611679 | In vitro combination characterization of the new anticancer plant drug beta-elemene with taxanes against human lung carcinoma. | 2007 Aug |
5 |
| 40 |
16080190 | Induction of tubulin by docetaxel is associated with p53 status in human non small cell lung cancer cell lines. | 2006 Jan 15 |
8 |
| 41 |
16391851 | Effect of apoptosis and response of extracellular matrix proteins after chemotherapy application on human breast cancer cell spheroids. | 2006 Feb |
4 |
| 42 |
16797627 | Azidothymidine and cisplatin increase p14ARF expression in OVCAR-3 ovarian cancer cell line. | 2006 Oct 1 |
6 |
| 43 |
16805818 | Predictive factors for response to docetaxel in human breast cancers. | 2006 Sep |
1 |
| 44 |
15970518 | Docetaxel induces p53-dependent apoptosis and synergizes with farnesyl transferase inhibitor r115777 in human epithelial cancer cells. | 2005 Sep 1 |
1 |
| 45 |
16169224 | When will more useful predictive factors be ready for use? | 2005 Dec |
1 |
| 46 |
15510008 | Enhancement of Ad-p53 therapy with docetaxel in head and neck cancer. | 2004 Nov |
8 |
| 47 |
12684687 | The effect of loss of Brca1 on the sensitivity to anticancer agents in p53-deficient cells. | 2003 May |
1 |
| 48 |
10811471 | Synergistic effects of adenovirus expressing wild-type p53 on chemosensitivity of non-small cell lung cancer cells. | 2000 Apr |
1 |
| 49 |
10405003 | Radiobiological effects of docetaxel (Taxotere): a potential radiation sensitizer. | 1999 Jun |
3 |
| 50 |
9703875 | Increased p21/WAF-1 and p53 protein levels following sequential three drug combination regimen of fludarabine, cytarabine and docetaxel induces apoptosis in human leukemia cells. | 1998 Jul-Aug |
1 |